AGC Biologics
Seattle, US · 2 known investors
AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
Founders & leadership
AS
Alberto SantagostinoinChief Executive Officer and PresidentChief Executive Officer and President at Agcbio
KM
Kasper MøllerinChief Technical Officer and Executive Vice President, Europe & Japan RegionsChief Technical Officer and Executive Vice President, Europe & Japan Regions at Agcbio
CW
YT
Yuichiro TashiroinExecutive Vice President, Corporate FunctionsExecutive Vice President, Corporate Functions at Agcbio
CM
Carrie MygattExecutive Vice President, Finance
LA
Luca AlbericiinExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan FacilityExecutive Vice President, Global Cell & Gene Technologies and General Manager, Milan Facility at Agcbio
KY
Kohei YokoyamaExecutive Vice President, Region Japan Facilitator
MA
Motoi AokiinHead of Global Quality
Investors · 2
Frequently asked questions
- What does AGC Biologics do?
- AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.
- Who are AGC Biologics's investors?
- AGC Biologics's investors include Boulder Ventures, European Equity Partners.
- Where is AGC Biologics headquartered?
- AGC Biologics is headquartered in Seattle, US.